miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny

被引:61
|
作者
Nimmo, Rachael [1 ]
Ciau-Uitz, Aldo [2 ]
Ruiz-Herguido, Cristina [3 ]
Soneji, Shamit [1 ]
Bigas, Anna [3 ]
Patient, Roger [2 ]
Enver, Tariq [1 ]
机构
[1] UCL Canc Inst, Stem Cell Lab, London WC1E 6BT, England
[2] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England
[3] PRBB, Inst Hosp Mar Invest Med IMIM, Canc Res Program, Barcelona 08003, Spain
关键词
STEM-CELL DEVELOPMENT; TGF-BETA INHIBITION; MICRORNA BIOGENESIS; AORTIC ENDOTHELIUM; EMBRYONIC BLOOD; UP-REGULATION; MOUSE; HEMATOPOIESIS; ADULT; LINEAGE;
D O I
10.1016/j.devcel.2013.06.023
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hematopoietic stem cells (HSCs) emerge during embryogenesis from hemogenic endothelium, but it remains unclear how the HSC lineage is initially established from mesoderm during ontogeny. In Xenopus, the definitive hemangioblast precursors of the HSC lineage have been identified in dorsal lateral plate (DLP) mesoderm, and a transcriptional gene regulatory network (GRN) controlling hemangioblast programming has been elucidated. Herein, we identify an essential role for microRNAs (miRNAs) in establishing the mesodermal lineage leading to both HSC emergence and vasculogenesis and determine that a single miRNA, miR-142-3p, is primarily responsible for initiation of definitive hemangioblast specification. miR-142-3p forms a double-negative gate unlocking entry into the hemangioblast program, in part by inhibiting TGF beta signaling. Our results table miR-142-3p as a master regulator of HSC lineage specification, sitting at the apex of the hierarchy programming the adult hemangioblast, thus illustrating that miRNAs can act as instructive determinants of cell fate during development.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [41] Reduced serum miR-142-3p predicates worse prognosis in patients with cervical cancer
    Lu, Jiahui
    Hang, Qi
    Cui, Yulan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3637 - 3643
  • [42] MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy
    Mansoori, Behzad
    Duijf, Pascal H. G.
    Mohammadi, Ali
    Safarzadeh, Elham
    Ditzel, Henrik J.
    Gjerstorff, Morten F.
    Cho, William Chi-Shing
    Baradaran, Behzad
    LIFE SCIENCES, 2021, 276
  • [43] Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
    Kaduthanam, Sajo
    Gade, Stephan
    Meister, Michael
    Brase, Jan C.
    Johannes, Marc
    Dienemann, Hendrik
    Warth, Arne
    Schnabel, Philipp A.
    Herth, Felix J. F.
    Sueltmann, Holger
    Muley, Thomas
    Kuner, Ruprecht
    LUNG CANCER, 2013, 80 (02) : 223 - 227
  • [44] MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis
    De Vito, Francesca
    Musella, Alessandra
    Fresegna, Diego
    Rizzo, Francesca Romana
    Gentile, Antonietta
    Bassi, Mario Stampanoni
    Gilio, Luana
    Buttari, Fabio
    Procaccini, Claudio
    Colamatteo, Alessandra
    Bullitta, Silvia
    Guadalupi, Livia
    Caioli, Silvia
    Vanni, Valentina
    Balletta, Sara
    Sanna, Krizia
    Bruno, Antonio
    Dolcetti, Ettore
    Furlan, Roberto
    Finardi, Annamaria
    Licursi, Valerio
    Drulovic, Jelena
    Pekmezovic, Tatjana
    Fusco, Clorinda
    Bruzzaniti, Sara
    Hornstein, Eran
    Uccelli, Antonio
    Salvetti, Marco
    Matarese, Giuseppe
    Centonze, Diego
    Mandolesi, Georgia
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48 (02)
  • [45] MiR-142-3p as an Indicator of OSA Severity Predicts Prognosis in Lung Adenocarcinoma with OSA
    Yang, Ting
    He, Fang
    Zhang, Mingxiang
    Ai, Li
    He, Meng
    Liu, Xin
    Li, Yongxia
    NATURE AND SCIENCE OF SLEEP, 2022, 14 : 2047 - 2054
  • [46] MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1
    Tan, Yi-Fan
    Chen, Zhi-Yuan
    Wang, Lei
    Wang, Min
    Liu, Xiu-Heng
    JOURNAL OF CANCER, 2020, 11 (06): : 1614 - 1624
  • [47] miR-142-3p Is a Regulator of the TGFβ-Mediated Vascular Smooth Muscle Cell Phenotype
    Kim, Kwangho
    Yang, Dong Kwon
    Kim, Sunghwan
    Kang, Hara
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (10) : 2325 - 2333
  • [48] miR-142-3p enhances FcεRI-mediated degranulation in mast cells
    Yamada, Yoji
    Kosaka, Kyoko
    Miyazawa, Tatsuya
    Kurata-Miura, Kazumi
    Yoshida, Tetsuo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (03) : 980 - 986
  • [49] Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity
    Fordham, Jezrom B.
    Naqvi, Afsar R.
    Nares, Salvador
    JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 98 (02) : 195 - 207
  • [50] Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation
    Dewi, Ihdina Sukma
    Hollander, Zsuzsanna
    Lam, Karen K.
    McManus, Janet-Wilson
    Tebbutt, Scott J.
    Ng, Raymond T.
    Keown, Paul A.
    McMaster, Robert W.
    McManus, Bruce M.
    Gidlof, Olof
    Ohman, Jenny
    PLOS ONE, 2017, 12 (01):